Frequency-dependent electrophysiological effects of flecainide, nifekalant and d,l-sotalol on the human atrium

24Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

To compare the effects of class Ic and III antiarrhythmic agents on the termination and prevention of atrial fibrillation, the present study investigated the use-dependent electrophysiological effects of flecainide, nifekalant and d,l-sotalol on the human atrium. Flecainide significantly prolonged effective refractory period (ERP), intra-atrial conduction time (IACT) and monophasic action potential duration (MAPD), and its effects on ERP and IACT were use-dependent. Nifekalalant significantly prolonged ERP and MAPD, and these effects were reverse use-dependent; however, there was no significant change in IACT. d,l-Sotalol significantly prolonged MAPD and the effect was reverse use-dependent. It significantly prolonged ERP, but the effect was not reverse use-dependent. d,l-Sotalol increased IACT in a use-dependent manner. Thus, for atrial fibrillation, class Ic antiarrhythmic agents might be more effective in termination and class III antiarrhythmic agents might be more effective in prevention.

Cite

CITATION STYLE

APA

Watanabe, H., Watanabe, I., Nakai, T., Oshikawa, N., Kunimoto, S., Masaki, R., … Kanmatuse, K. (2001). Frequency-dependent electrophysiological effects of flecainide, nifekalant and d,l-sotalol on the human atrium. Japanese Circulation Journal, 65(1), 1–6. https://doi.org/10.1253/jcj.65.1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free